Source: Annual Congress 2008 - Various aspects of thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Yilmaz Kaymaz, B. Akkalyoncu, F. Ugurman, U. Onde, B. Samurkasoglu, A. Gozu, G. Onde Ucoluk (Ankara, Turkey). Relation between bone metastasis in lung cancer and serum IL-6 levels. Eur Respir J 2008; 32: Suppl. 52, 2658

Member's Comments

No comment yet.

Related content which might interest you: Increased serum levels of IL-18 are associated with lower survival and bone metastasis in non-small-cell lung cancer Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002 Serum levels of interleukin 8 and plasma levels of osteopontin in patients with non-small cell lung cancer during chemotherapy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Clinical significance of serum osteopontin levels in lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Serum levels of STR-3 and TIMP-2 in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Clinical significance of serum adipokines levels in lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 The correlation of serum tumor markers and distant metastasis in lung adenocarcinoma Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Evaluation of serum levels of Sirtuin-1 in lung cancer patients Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease. Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003 Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Serum levels of sFas and sFasL during chemotherapy of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 329s Year: 2005 Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Usefulness of bone metabolic markers in the bone metastasis from lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002 Serum level of interleukin-6 as a prognostic factor in advanced nonsmall-cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005 A serum level of IGF-I and IGFBP-3 in patients with lung cancer during chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 329s Year: 2005 Serum hepcidin and iron are associated with non-small cell lung cancer stage Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016